Ordering
Available Variants5 mg
CHA.21456-5mg
Price
€60.24
Available – Dispatch in 14 days
25 mg
CHA.21456-25mg
Price
€240.80
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
5 mg | CHA.21456-5mg | €60.24 |
|
Available – Dispatch in 14 days
Global Network - International delivery
|
25 mg | CHA.21456-25mg | €240.80 |
≥98% (HPLC), powder, mitochondrial division DRP inhibitor
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C15H10Cl2N2O2S |
|---|---|
| CAS Number | 338967-87-6 |
| Molecular Weight | 353.22 |
| UNSPSC Code | 12352200 |
| PubChem Substance ID | 329817738 |
| NACRES | NA.77 |
| MDL number | MFCD00974506 |
| Assay | ≥98% (HPLC) |
| Form | powder |
| Quality level | 100 |
Safety Information Handling visibility
| Storage Class | 11 - Combustible Solids |
|---|---|
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
Technical Overview & Applications Use-case context
Mdivi-1, also known by its CAS number 338967-87-6, is a potent inhibitor of mitochondrial division, specifically targeting the dynamin-related protein Drp1. This small molecule has been extensively utilized in research to investigate the role of mitochondrial dynamics in various cellular processes, including apoptosis, cell signaling, and metabolism. By inhibiting Drp1-mediated mitochondrial fission, Mdivi-1 promotes mitochondrial fusion, leading to changes in mitochondrial morphology and function. Studies have demonstrated the potential therapeutic applications of Mdivi-1 in diseases characterized by mitochondrial dysfunction, such as neurodegenerative disorders and cancer. Furthermore, Mdivi-1 has been shown to exert protective effects against ischemia-reperfusion injury and other forms of cellular stress, highlighting its potential as a valuable tool for understanding mitochondrial biology and developing novel therapeutic strategies. Its use has contributed significantly to the understanding of mitochondrial dynamics and its role in disease pathogenesis.
